Literature DB >> 240475

Effects of narcotic analgesic drugs on the cyclic adenosine 3',5'-monophosphate-adenylate cyclase system in rat brain.

D H Clouet, G J Gold, K Iwatsubo.   

Abstract

1. The concentrations of cyclic adenosine 3',5'-monophosphate (cyclic AMP), measured in discrete brain areas removed from rats killed by microwave irradiation, rose transiently in most areas after the administration of morphine. The most pronounced changes, however, were found 2 h after doses of either 10 or 60 mg/kg morphine when cyclic AMP levels declined significantly in the hypothalamus, medulla and cerebellum. In morphine-tolerant rat brains there were no decreases in cyclic AMP levels. 2. Basal adenylate cyclase activity in crude nerve-ending fractions from discrete areas of rat brain was unaffected by the addition of active analgesic agonists, antagonists or inactive isomers to the assay medium in vitro, except for a nonspecific inhibition at drug concentrations of 1 mM. 3. The acute administration of morphine or levorphanol, but not dextrorphan produced transient increases in basal cyclase activity of crude nerve-ending preparations from midbrain and striatum. In morphine-tolerant rats, these changes in basal adenylate cyclase activity were no longer seen.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240475      PMCID: PMC1666673          DOI: 10.1111/j.1476-5381.1975.tb07602.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Effect of morphine administration on adenyl cyclase and 3',5'-cyclic nucleotide phosphodiesterase activities in the brain.

Authors:  K Naito; K Kuriyama
Journal:  Jpn J Pharmacol       Date:  1973-04

3.  Cyclic AMP in brain areas: effects of amphetamine and norepinephrine assessed through the use of microwave radiation as a means of tissue fixation.

Authors:  M J Schmidt; J T Hopkins; D E Schmidt; G A Robison
Journal:  Brain Res       Date:  1972-07-20       Impact factor: 3.252

4.  Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase.

Authors:  A A White; T V Zenser
Journal:  Anal Biochem       Date:  1971-06       Impact factor: 3.365

5.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

6.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

7.  Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system.

Authors:  J M Hiller; J Pearson; E J Simon
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-11

8.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

9.  Regulation of cyclic AMP levels in brain tissue.

Authors:  J W Daly; M Huang; H Shimizu
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

10.  Letter: Brain adenyl cyclase in methadone treatment of morphine dependency.

Authors:  R L Singhal; S Kacew; R Lafreniere
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

View more
  2 in total

1.  Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

2.  Effect of capsaicin on morphine analgesia--possible involvement of hypothalamic structures.

Authors:  G Jancsó; A Jancsó-Gábor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.